Reconstitution

Work out your draw

Enter what's in the vial and the dose you intend to take. The syringe below shows the exact mark to pull to.

Draw to10units
Volume0.10 mL
Concentration2.5 mg/mL
Per unit25 mcg

Yield

What this vial gives you

20
Full doses
20
Days of supply
28
Fridge days once mixed
Once reconstituted, most peptides are treated as good for about 28 days refrigerated at 2–8 °C. If your vial outlasts that window, the fridge clock is the binding limit, not the number of doses left.

New entry

Log an injection

Site — coolest zone is outlined

Rotate systematically and stay at least a finger's width from your last mark. Skip any zone that is lumpy, hardened or sore — absorption there is unpredictable.

History

Your log

0
Entries
0
Last 7 days
0
Day streak
Since last shot

Stock

Add a reconstituted vial

Track concentration, how much is left, and how many fridge days remain before the mixed solution is past the usual 28-day window.

In the fridge

Open vials

Reference

Compound library

Every number is tagged by where it came from. Clinical means a human trial or approved label. Community means a protocol circulated by vendors, clinics or forums with no human dose-ranging trial behind it.

Combinations

What gets stacked, and what shouldn't

This is a record of combinations that are commonly reported and the reasoning given for them — not a recommendation engine. Nothing here is telling you what to take.

Every combination below multiplies unknowns. Two compounds with thin human data do not become better evidenced by being taken together, and side effects that overlap (nausea, blood pressure, fluid retention) add up rather than cancel.

Before you buy a pre-mixed vial

Three things about blends

  • The names mean nothing official. Wolverine, GLOW and KLOW are nicknames vendors and forums attached to combinations. None is a brand, a drug name or a regulated product, and different suppliers sell different ratios under the same name. Always read your own vial label.
  • You lose the ability to adjust one component. The ratio is set when the vial is made. If one part disagrees with you, the only lever you have is dropping the whole blend.
  • Pre-mixing raises a stability question. For the GHK-Cu blends specifically, GHK-Cu is reported most stable around pH 5.5 to 6.5 while BPC-157 is normally handled near neutral. Critics argue pre-mixed GLOW and KLOW lose potency over time because of that mismatch; manufacturers dispute it. Independent stability data on pre-mixed blends is limited. Buying the components separately sidesteps the question entirely, and lets you dose them properly — BPC-157 and TB-500 are normally run on completely different scales and schedules.

Storage

Your data

Everything lives in this browser on this device. Nothing is uploaded, and there is no account. Clearing your browser data will wipe it — export a backup if it matters to you.

0
Log entries
0
Vials
Storage
1
Profiles
Free
Version
Build

Appearance

Light or dark

Dark switches on with your phone at night — kinder at 6am.

Guided opens the "where do these numbers come from" panels by default. They stay one tap away either way.

This app

Install on this phone

Puts MilliMark in your app drawer like any other app — full screen, works offline, opens from its own icon.

Safety flag boxes

Open or minimised

The red flag boxes in the library can start minimised — the header and count always stay, and any box you open stays how you left it.

App lock

Four-digit code on open

Keeps casual eyes out when the phone gets handed around. It is a deterrent, not encryption — the data underneath is unchanged.

Terms

What you agreed to

Read the terms again

What this is. MilliMark performs arithmetic on numbers you enter and keeps a record of what you log. That is the whole product. It is not medical advice, it does not diagnose or treat anything, and it will never tell you what to take or how much to take.

The reference library. Figures are reproduced from published trials, approved product labels, and protocols circulating among vendors and clinics. Each is tagged with which of those it came from. Community-tagged figures have no human trial behind them and several are scaled from animal studies. No figure here is a recommendation, and the library going stale is a real risk — check the review date.

Accuracy. Every effort is made to reproduce sources correctly, but no warranty is given that any figure is accurate, current or complete. Verify anything you intend to act on. A calculator cannot know whether your vial holds what its label claims, and grey-market supply is routinely mislabelled.

Your responsibility. You decide what you do. MilliMark accepts no liability for any outcome arising from use of this app, to the fullest extent the law allows. If you are unwell, pregnant, taking prescription medication, or under 18, speak to a doctor instead of using this.

Payment. The full version is a one-off purchase, not a subscription. There is nothing to cancel. If it does not work for you, ask for a refund.

Privacy

Nothing leaves this device

This is short because there is almost nothing to say.

  • No account, no sign-up, no email required to use it.
  • No analytics, no tracking pixels, no third-party scripts watching you.
  • Your log, cycle, vials, bloodwork and photos are stored only in this browser, on this device. They are never uploaded.
  • Suggestions you send contain only what you type in that form. Nothing is attached from your data.
  • If you buy the full version, the payment processor handles your card and holds your email. MilliMark never sees your card details.
The flip sideNobody can recover your data for you. Lose the device or clear your browser storage and it is gone. Photos are stored unencrypted, so anyone who can unlock this phone can open them. Export backups if any of it matters.

Provenance

Where the reference data came from

Clinical figures are drawn from trial publications and approved product labels — among them the STEP 1 (semaglutide), SURMOUNT-1 (tirzepatide) and retatrutide Phase 2 trials in the New England Journal of Medicine, the Teichman CJC-1295 pharmacokinetic study, the Adunsky MK-677 hip-fracture trial, and the FDA labels for Egrifta, Vyleesi and Scenesse.

Community figures come from vendor and clinic protocol pages. Those sources are secondary, not peer-reviewed, and several sell the products they describe. They are included because they reflect what is actually circulating, not because they are reliable.